Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Patent
1995-02-17
1996-12-24
Tsang, Cecilia
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
514 80, 514212, 514 79, 514 84, 514 89, 514 90, 514 91, 540523, 540487, 540524, 540527, C07D22332, A61K 3155
Patent
active
055873758
ABSTRACT:
Compounds having the following formulae I and II, and pharmaceutically acceptable salts thereof, including dual inhibitors of ACE and NEP and selective ACE inhibitors: ##STR1## and wherein R, R.sup.1, R.sup.2, R.sup.3, R.sup.4, R.sup.5, R.sup.5a, R.sup.5b, R.sup.6, R.sup.7, R.sup.11, q and r are defined herein.
REFERENCES:
patent: 3856798 (1974-12-01), Meyer et al.
patent: 4105776 (1978-08-01), Ondetti et al.
patent: 4186200 (1980-01-01), Kubo et al.
patent: 4192945 (1980-03-01), Ondetti
patent: 4225495 (1980-09-01), Ondetti
patent: 4337201 (1982-06-01), Petrillo, Jr.
patent: 4339600 (1982-07-01), Ondetti et al.
patent: 4374829 (1983-02-01), Harris et al.
patent: 4409146 (1993-10-01), Thorsett et al.
patent: 4410520 (1983-10-01), Watthey
patent: 4415496 (1983-11-01), Harris et al.
patent: 4432971 (1984-02-01), Karanewsky et al.
patent: 4432972 (1984-02-01), Karanewsky et al.
patent: 4460579 (1984-07-01), Karanewsky
patent: 4465679 (1984-08-01), Huang et al.
patent: 4470988 (1984-09-01), Watthey
patent: 4473575 (1984-09-01), Watthey
patent: 4477464 (1984-10-01), Slade et al.
patent: 4512924 (1985-04-01), Attwood et al.
patent: 4537885 (1985-08-01), Watthey
patent: 4539150 (1985-09-01), Katakami et al.
patent: 4548932 (1985-10-01), Sugihara et al.
patent: 4575503 (1986-03-01), Watthey
patent: 4584294 (1986-04-01), Ruyle
patent: 4587050 (1986-05-01), Harris et al.
patent: 4587238 (1986-05-01), Harris et al.
patent: 4594341 (1986-06-01), Cheung et al.
patent: 4617301 (1986-10-01), Patchett et al.
patent: 4629787 (1986-12-01), Harris et al.
patent: 4680392 (1987-07-01), Harris et al.
patent: 4699905 (1987-10-01), Yanagisawa et al.
patent: 4711884 (1987-12-01), Karanewsky
patent: 4722810 (1988-02-01), Delaney et al.
patent: 4734410 (1988-03-01), Yanagisawa et al.
patent: 4749688 (1988-06-01), Haslanger et al.
patent: 4801609 (1989-01-01), Haslanger et al.
patent: 4824832 (1989-04-01), Flynn et al.
patent: 4857520 (1989-08-01), Urbach et al.
patent: 4873235 (1989-10-01), Parsons et al.
patent: 4879309 (1989-11-01), Doll et al.
patent: 4963539 (1990-10-01), Delaney
patent: 4973585 (1990-11-01), Flynn et al.
patent: 5061710 (1991-10-01), Haslanger et al.
patent: 5075302 (1991-12-01), Neustadt
patent: 5098934 (1992-03-01), Vevert et al.
patent: 5190974 (1993-03-01), Clemence et al.
patent: 5208236 (1993-05-01), Neustadt
patent: 5223516 (1993-06-01), Delaney et al.
patent: 5225401 (1993-07-01), Seymour
patent: 5232920 (1993-08-01), Neustadt
patent: 5238924 (1993-08-01), Smith
patent: 5262436 (1993-11-01), Haslanger et al.
patent: 5362727 (1994-11-01), Robl
patent: 5366973 (1994-11-01), Flynn et al.
Adams et al., Synthetic Communications, vol. 18, 2225-2231 (1988).
Attwood et al., FEBS Letters, vol. 165, pp. 201-206 (1984).
Attwood et al., J. Chem. Soc. Perkin Trans I (1986) pp. 1011-1019.
Bolos et al., J. Org. Chem., 57, 3535-3539 (1992).
Bolos et al., Tetrahedron, vol. 48, pp. 9567-9576 (1992).
Boyer, T. D. "Cirrhosis of the Liver and Its Major Sequelae" in: Wyngaarden, J. B. et al., Cecil Textbook of Medicine, vol. 1 (Saunders Co., 1992) pp. 786-789.
Chackalamannil et al., Bioorganic & Medicinal Chemistry Letters, vol. 2, pp. 1003-1006 (1992).
Das et al., Bioorganic & Medicinal Chemistry Letters, vol. 4, pp. 2193-2198 (1994).
Delaney et al., Bioorganic & Medicinal Chemistry Letters, vol. 4, pp. 1783-1788 (1994).
Dussaule et al., Jour. of Clinical Endocrinology and Metabolism, vol. 72, pp. 653-659 (1991).
Fernandez-Cruz, The Lancet, Dec. 21/28, pp. 1439-1440 (1985).
Flynn et al., J. Med. Chem., 36, pp. 2420-2423 (1993).
Flynn, Tetrahedron Letters, vol. 31, pp. 815-818 (1990).
Fobian et al., 206th Meeting of the Amer. Chem. Society, Aug. 1993 Abstr. ORG 297.
Fyhrquist et al., The Lancet, Dec. 21/28, p. 1439 (1985).
Hanau et al., 206th Meeting of the Amer. Chem. Society, Aug. 1993 Abstr. ORG 298.
Itoh et al., Chem. Pharm. Bull., vol. 34, pp. 1128-1147 (1986).
Itoh et al., Chem. Pharm. Bull., vol. 34, pp. 2078-2089 (1986).
Laffi et al., Gastroenterology, vol. 96, pp. 167-177 (1989).
Moeller et al., Tetrahedron Letters, vol. 33, pp. 6041-6044 (1992).
Naming and Indexing of Chemical Substances for Chemical Abstracts, 1987 Index Guide, Section 203.
Natoff et al., Drugs Of the Future, vol. 12, pp. 475-483 (1987).
Parsons et al., Biochem and Biophysical Research Comm. 117, pp. 108-113 (1983).
Robl et al., Bioorganic & Medicinal Chem. Letters, vol. 4, pp. 1795-1800 (1994).
Robl et al., Bioorganic & Medicinal Chemistry Letters, vol. 4, pp. 1789-1794 (1994).
Robl et al., Bioorganic & Medicinal Chemistry Letters, vol. 4, pp. 2055-2060 (1994).
Robl et al., J. Am. Chem. Soc., 116, pp. 2348-2355 (1994).
Robl, Tetrahedron Letters, vol. 35, pp. 393-396 (1994).
Robl, Tetrahedron Letters, vol. 35, pp. 1393-1396 (1994).
Slade et al., J. Med. Chem., 28, pp. 1517-1521 (1985).
Smith et al., Biochemistry, vol. 14, pp. 766-771 (1975).
Thorsett et al., J. Med. Chem., 29, pp. 251-260 (1986).
Thorsett, Actual Chim. Ther., vol. 13, pp. 257-268 (1986).
Watthey et al., J. Med. Chem., 28, pp. 1511-1516 (1985).
Yanagisawa et al., J. Med. Chem., 30, pp. 1984-1991 (1987).
Yanagisawa et al., J. Med. Chem., 31, pp. 422-428 (1988).
Babajko Suzanne E.
Bristol--Myers Squibb Company
Tsang Cecilia
Wong King Lit
LandOfFree
Azepinone compounds useful in the inhibition of ACE and NEP does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Azepinone compounds useful in the inhibition of ACE and NEP, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Azepinone compounds useful in the inhibition of ACE and NEP will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1178670